These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11778589)

  • 41. Clinical trial design in systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generalizing results of randomized trials to clinical practice: reliability and cautions.
    Flather M; Delahunty N; Collinson J
    Clin Trials; 2006; 3(6):508-12. PubMed ID: 17170034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What must research subjects be told regarding the results of completed randomized trials?
    Markman M
    IRB; 2004; 26(3):8-10. PubMed ID: 15281194
    [No Abstract]   [Full Text] [Related]  

  • 44. A simple sample size formula for analysis of covariance in randomized clinical trials.
    Borm GF; Fransen J; Lemmens WA
    J Clin Epidemiol; 2007 Dec; 60(12):1234-8. PubMed ID: 17998077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organising clinical research: 3. Trial design.
    Mapleson WW
    Br J Clin Pract; 1989 Mar; 43(3):89-93. PubMed ID: 2692689
    [No Abstract]   [Full Text] [Related]  

  • 46. Is melatonin useful in alopecia: critical appraisal of a randomized trial?
    Sladden MJ; Hutchinson PE
    Br J Dermatol; 2005 Oct; 153(4):859-60; author reply 860-1. PubMed ID: 16181483
    [No Abstract]   [Full Text] [Related]  

  • 47. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A general statistical principle for changing a design any time during the course of a trial.
    Müller HH; Schäfer H
    Stat Med; 2004 Aug; 23(16):2497-508. PubMed ID: 15287080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Issues in the planning and conduct of randomised trials.
    Bhandari M; Pape HC; Giannoudis PV
    Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 53. Industry collaboration and randomized clinical trial design and outcomes.
    Roper N; Zhang N; Korenstein D
    JAMA Intern Med; 2014 Oct; 174(10):1695-6. PubMed ID: 25156272
    [No Abstract]   [Full Text] [Related]  

  • 54. On the usefulness of outcome-adaptive randomization.
    Yuan Y; Yin G
    J Clin Oncol; 2011 May; 29(13):e390-2; author reply e393. PubMed ID: 21422433
    [No Abstract]   [Full Text] [Related]  

  • 55. When should an interim analysis be unblinded to the data monitoring committee?
    Knottnerus JA; Spigt MG
    J Clin Epidemiol; 2010 Apr; 63(4):350-2. PubMed ID: 19762210
    [No Abstract]   [Full Text] [Related]  

  • 56. Estimating causal effect with randomized controlled trial.
    Shrier I
    Epidemiology; 2013 Sep; 24(5):779-81. PubMed ID: 23903885
    [No Abstract]   [Full Text] [Related]  

  • 57. Monitoring clinical trials. Latest data from START trial should be made available.
    Henk JM
    BMJ; 2001 Dec; 323(7326):1425-6. PubMed ID: 11778592
    [No Abstract]   [Full Text] [Related]  

  • 58. Adaptive clinical trials: the promise and the caution.
    Berry DA
    J Clin Oncol; 2011 Feb; 29(6):606-9. PubMed ID: 21172875
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical epidemiology--therapy].
    Janout V
    Cas Lek Cesk; 2004; 143(2):117-21. PubMed ID: 15077576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How to ... do a randomized controlled trial.
    O'Brien KD; Wright JL; Mandall NA
    J Orthod; 2003 Dec; 30(4):337-41. PubMed ID: 14634173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.